Jackson Acquisition CO Ii

Jackson Acquisition Company II received a notice from the NYSE for failing to meet the minimum 300 public stockholders requirement, initiating a compliance period.

Jackson Acquisition Company II announces that starting January 30, 2025, holders of its units can separately trade the Class A ordinary shares and rights included in those units.

Jackson Acquisition Company II successfully closed its initial public offering (IPO), raising $230 million to pursue a business combination in the healthcare industry.

Jackson Acquisition Company II successfully closed its initial public offering, raising $230 million to pursue a business combination in the healthcare industry.

Jackson Acquisition Company II reports Q3 2025 net income driven by trust account interest, as it continues its search for a healthcare business combination target ahead of its December 2026 deadline.

Jackson Acquisition Company II, a SPAC targeting healthcare, reported a net income of $2.3 million for Q2 2025, primarily from interest on its $237.7 million trust account.

Jackson Acquisition Company II, a blank check company, reported a net income of $2.2 million for the quarter ended March 31, 2025, primarily driven by interest earned on marketable securities held in trust.

Jackson Acquisition Company II, a healthcare-focused SPAC, files its first quarterly report since its inception and recent IPO, detailing formation activities and initial financial position.

Jackson Acquisition Company II, a SPAC focused on healthcare, reported a net income of $9.1 million for 2025 while actively seeking its initial business combination by December 2026.

Jackson Acquisition Company II, a blank check company, details its structure, strategy, and financial condition in its annual report on Form 10-K, emphasizing its focus on healthcare-related business combinations.

Jackson Acquisition Company II has filed an amended rights agreement detailing the terms of rights issuance in connection with its upcoming initial public offering.

Jackson Acquisition Company II, a blank check company, has filed an amendment to its registration statement for a $200 million initial public offering, with a focus on acquiring businesses in the healthcare services and technology sectors.

Jackson Acquisition Company II, a blank check company, has filed an amendment to its registration statement for a $200 million initial public offering, with a focus on acquiring businesses in the healthcare services and technology industries.

Jackson Acquisition Company II, a blank check company, aims to raise $200 million through an IPO to pursue a business combination within the healthcare industry.

Jackson Acquisition Company II, a newly formed blank check company, has filed for a $200 million IPO to pursue a business combination within the healthcare industry.

Meteora Capital, LLC, along with its managing member Vik Mittal, has reported beneficial ownership of 1,219,744 shares, representing 5.11% of the Class A Common Stock of Jackson Acquisition Co II.

AQR Capital Management, through its subsidiaries, has reported a beneficial ownership stake of 4.88% in Jackson Acquisition Co II's Class A ordinary shares.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 3.1% of Jackson Acquisition Co II's Class A ordinary shares.

HGC Investment Management Inc. has reported a 6.19% beneficial ownership stake in Jackson Acquisition Company II, holding 1,475,200 Class A Common Stock shares as of December 31, 2025.

Bank of Montreal and its affiliates have filed an amended Schedule 13G, reporting 0% beneficial ownership of Jackson Acquisition Co II's Class A ordinary shares.

Meteora Capital, LLC, an investment adviser, has disclosed a 6.04% beneficial ownership stake in Jackson Acquisition Co II's Class A common stock.